PTPRD: A Positive Predictive Biomarker for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

被引：0
|
作者：
Shen, J. [1 ]
Zhou, H. [2 ]
Liu, J. [2 ]
Zhang, Y. [2 ]
Zhou, T. [2 ]
Hong, S. [2 ]
Zhao, Y. [2 ]
Yang, Y. [2 ]
Zhao, H. [3 ]
Huang, Y. [2 ]
Fang, W. [2 ]
Zhang, L. [2 ]
机构：
[1] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Clin Res, Ctr Canc, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
NSCLC; Immunotherapy; Notch;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P14.14
引用
收藏
页码：S335 / S336
页数：3
相关论文
共 50 条
  • [1] Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
    Liu, Xiaoming
    Cho, William C.
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
  • [2] ZFHX4 mutation as a novel predictive biomarker for immune checkpoint blockade in non-small cell lung cancer.
    Shen, Peng
    Zeng, Di
    Lin, Zhenzi
    Lin, Pei
    Luo, Mingyang
    Zhao, Lele
    Chai, Huizi
    Huang, Lingli
    Xiao, Mingzhe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Immune Checkpoint Therapy in Non-Small Cell Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    [J]. CANCER JOURNAL, 2016, 22 (02): : 81 - 91
  • [4] Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer
    Califano, Raffaele
    Kerr, Keith
    Morgan, Robert David
    Lo Russo, Giuseppe
    Garassino, Marina
    Morgillo, Floriana
    Rossi, Antonio
    [J]. CURRENT ONCOLOGY REPORTS, 2016, 18 (09)
  • [5] Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer
    Raffaele Califano
    Keith Kerr
    Robert David Morgan
    Giuseppe Lo Russo
    Marina Garassino
    Floriana Morgillo
    Antonio Rossi
    [J]. Current Oncology Reports, 2016, 18
  • [6] PTPRD/PTPRT mutations as potential positive predictor for response of immune checkpoint inhibitors in non-small cell lung cancer (NSCLC).
    Zeng, Jian
    Wang, Guoqiang
    Yan, Zhengqing
    Zheng, Hao
    Li, Jianqiang
    Tao, Feng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer
    Jiexia Zhang
    Ningning Zhou
    Anqi Lin
    Peng Luo
    Xin Chen
    Huojin Deng
    Shijun Kang
    Linlang Guo
    Weiliang Zhu
    Jian Zhang
    [J]. Cancer Immunology, Immunotherapy, 2021, 70 : 137 - 151
  • [8] ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer
    Zhang, Jiexia
    Zhou, Ningning
    Lin, Anqi
    Luo, Peng
    Chen, Xin
    Deng, Huojin
    Kang, Shijun
    Guo, Linlang
    Zhu, Weiliang
    Zhang, Jian
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) : 137 - 151
  • [9] A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
    Jiang, Zedong
    Zhou, Yao
    Huang, Juan
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Ushio, Ryota
    Murakami, Shuji
    Saito, Haruhiro
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
12345